Masimo found out about restoration of pulse oximetry to the Apple Watch the same way that the rest of the world did, and is suing US Customs and Border Protection to stop the process. It seems Apple ...

Apple removed blood oxygen monitoring from the Apple Watch in early 2024. Somebody has to blink for it to return, and it looks like neither Masimo nor Apple are going to budge. Blood oxygen monitoring ...

Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than 100 ...

Apple has been selling the Apple Watch Series 9 and Apple Watch Ultra 2 without the blood oxygen monitoring feature in the U.S. since mid-January, and while we've suspected Apple would be able to ...

Apple on Thursday began selling revised models of the Apple Watch Series 9 and Ultra 2 in the US without the blood oxygen feature as the company faces a patent dispute with medical company Masimo. In ...

Masimo is taking the U.S. government to court over its decision to allow blood oxygen tracking to return to the Apple Watch, saying its decision was unlawful and that Apple’s workaround still ...

Apple convinced a federal jury on Friday that health monitoring tech company Masimo’s smartwatches infringe two of its design patents. The jury, in Delaware, agreed with Apple that Masimo’s W1 and ...

“According to Masimo, the CBP ‘inexplicably reversed course’ from its prior rulings in finding that Apple could overcome the LEO by shipping its smartwatches separately from iPhones.” On Wednesday, ...

Masimo Corp. ((MASI)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat ® Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available ...